BeiGene, Ltd. (ONC) Stock Price
BeiGene, Ltd. Price
Revenue has compounded at 67.3% per year over the past 12 years to 5.34 B USD. BeiGene, Ltd.'s net margin stands at 5.4%, up from -123.9% several years earlier. Analysts set a median price target of 400.00 USD, implying 2.7% below the current price. Of 11 analysts, 10 rate the stock a buy — an overall Buy consensus.
BeiGene, Ltd. stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
BeiGene, Ltd. business model & stock analysis
Frequently asked questions about BeiGene, Ltd.
Analysts currently set an average price target of 400.67 USD for the BeiGene, Ltd. stock (median: 400.00 USD), implying -3.0 % versus the latest price. The consensus is based on 11 analyst ratings.
11 analysts currently rate the BeiGene, Ltd. stock: 10 recommend buying, 1 holding and 0 selling. For 2026, analysts expect BeiGene, Ltd. to generate revenue of 6.98 B USD and earnings per share of 7.41 USD.
Converted at the current exchange rate, the BeiGene, Ltd. share trades at 374.79 EUR (411.29 USD).
The expected revenue of BeiGene, Ltd. is 6.98 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of BeiGene, Ltd. is 840.12 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of BeiGene, Ltd. is currently 55.54. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the BeiGene, Ltd. stock.
The price-to-sales ratio (P/S) of BeiGene, Ltd. is currently 6.69. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the BeiGene, Ltd. stock.
The Eulerpool Quality Score for BeiGene, Ltd. is 6/10.
The ISIN of BeiGene, Ltd. is US07725L1026. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of BeiGene, Ltd. is ONC. The ticker symbol is used to trade BeiGene, Ltd. shares on the stock exchange.
BeiGene, Ltd. stock
BeiGene, Ltd. Peer Group
All fundamentals and in-depth analysis of BeiGene, Ltd.
Our stock analysis for BeiGene, Ltd. stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BeiGene, Ltd.. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.